HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemorrhagic shock and encephalopathy syndrome

Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Thrombotic Microangiopathies
2. Seizures (Absence Seizure)
3. Hypothermia
4. Brain Diseases (Brain Disorder)
5. Autoimmune Diseases (Autoimmune Disease)

Experts

1. Ishida, Yusuke: 2 articles (03/2022 - 01/2021)
2. Kurosawa, Hiroshi: 2 articles (03/2022 - 01/2021)
3. Maruyama, Azusa: 2 articles (03/2022 - 01/2021)
4. Nagase, Hiroaki: 2 articles (03/2022 - 01/2021)
5. Nishiyama, Masahiro: 2 articles (03/2022 - 01/2021)
6. Nozu, Kandai: 2 articles (03/2022 - 01/2021)
7. Tanaka, Ryojiro: 2 articles (03/2022 - 01/2021)
8. Tokumoto, Shoichi: 2 articles (03/2022 - 01/2021)
9. Tomioka, Kazumi: 2 articles (03/2022 - 01/2021)
10. Toyoshima, Daisaku: 2 articles (03/2022 - 01/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hemorrhagic shock and encephalopathy syndrome:
1. Growth Differentiation Factor 15IBA
2. ChemokinesIBA
3. CytokinesIBA
4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
5. Creatine Kinase (Creatine Phosphokinase)IBA
6. Aspartate Aminotransferases (Aspartate Transaminase)IBA

Therapies and Procedures

1. Therapeutics
2. Induced Hypothermia
3. Critical Care (Surgical Intensive Care)